FreeportMcMoRan (FCX)
(Delayed Data from NYSE)
$50.65 USD
+1.94 (3.98%)
Updated Jul 3, 2024 01:00 PM ET
After-Market: $50.69 +0.04 (0.08%) 7:58 PM ET
3-Hold of 5 3
C Value C Growth B Momentum C VGM
Price, Consensus and EPS Surprise
FCX 50.65 +1.94(3.98%)
Will FCX be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for FCX based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for FCX
Freeport (FCX) Starts Commissioning of New Indonesian Smelter
Freeport-McMoRan (FCX) Ascends While Market Falls: Some Facts to Note
FCX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Investors Heavily Search Freeport-McMoRan Inc. (FCX): Here is What You Need to Know
Should You Invest in the iShares U.S. Basic Materials ETF (IYM)?
Freeport-McMoRan (FCX) Rises As Market Takes a Dip: Key Facts
Other News for FCX
Quest Diagnostics, Southwest Airlines rise; Simulations Plus falls, Wednesday, 7/3/2024
Freeport Commences Commissioning of New Indonesian Smelter and Provides Update on Second-Quarter 2024 Copper and Gold Sales
Nike, Kura Sushi fall; Infinera, Protagonist Therapeutics rise, Friday, 6/28/2024
7 Stocks, 5 ETFs Move On Friday As Fed's Preferred Inflation Rate Hits 3-Year Low
New Buy Rating for Freeport-McMoRan (FCX), the Basic Materials Giant